儿童、青少年和年轻成人癌症幸存者中随后发生的无症状脑膜瘤筛查与管理实践差异
该研究通过在线调查评估国际临床医生对接受颅脑放疗的儿童、青少年和年轻成人(CAYA)癌症幸存者中随后发生的无症状脑膜瘤的筛查与管理实践,发现筛查意愿和决策因素存在国际差异,决策主要基于临床特征,这些见解将为监测指南提供信息。
要点
- 医生愿意筛查以检出1例脑膜瘤的CAYA幸存者数量范围为0至750(中位数50)。
- 医生对MRI筛查的危害表示担忧,包括不必要的干预风险(n=25,73%)和过度诊断(n=19,56%)。
- 生长模式(n=33,97%)、位置(n=31,91%)和大小(n=29,85%)是影响治疗无症状脑膜瘤决策的最重要因素。
核心结论
- 国际间对于高危CAYA癌症幸存者中随后发生的无症状脑膜瘤的筛查意见和临床实践存在差异。
- 对无症状脑膜瘤的干预决策在很大程度上由临床特征驱动。
- 这些对当前临床实践的宝贵见解将为CAYA癌症幸存者的监测指南提供信息。
研究设计与样本
- 研究创建了一项在线调查,以确定当前国际临床实践关于CAYA癌症幸存者中随后发生的无症状脑膜瘤的筛查和管理。
- 邀请了来自北美和欧洲的59名具有脑膜瘤相关专业知识的医生参与。
- 34名医生(58%)完成了调查。
主要发现
- 医生愿意筛查以检出1例脑膜瘤的CAYA癌症幸存者数量报告范围为0至750(中位数50)。
- 医生对MRI筛查的危害表示担忧,包括不必要的干预风险(n=25,73%)和过度诊断(n=19,56%)。
- 生长模式(n=33,97%)、位置(n=31,91%)和大小(n=29,85%)被认可为影响治疗无症状脑膜瘤决策的最重要因素。
- 具有挑战性的位置(n=14,52%)、惰性肿瘤生长模式(n=13,48%)和无症状(n=12,44%)被认可为监测而不干预的主要原因。
关键数值与推荐
- 医生愿意筛查以检出1例脑膜瘤的CAYA癌症幸存者数量范围为0至750(中位数50)。
- 不必要的干预风险被25名医生(73%)认可,过度诊断被19名医生(56%)认可。
- 生长模式被33名医生(97%)认可,位置被31名医生(91%)认可,大小被29名医生(85%)认可为影响治疗决策的最重要因素。
- 具有挑战性的位置被14名医生(52%)认可,惰性肿瘤生长模式被13名医生(48%)认可,无症状被12名医生(44%)认可为监测而不干预的主要原因。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Childhood, adolescent and young adult (CAYA) cancer survivors treated with cranial radiotherapy are at risk for developing subsequent meningiomas. There is insufficient evidence concerning the benefits and harms of screening for subsequent meningiomas, and uncertainty about the most appropriate clinical management of asymptomatic meningiomas. Data describing current clinical decision-making is essential to formulate surveillance recommendations. METHODS: We created an online survey to identify the current international clinical practice regarding screening for and management of subsequent asymptomatic meningiomas among CAYA cancer survivors. Fifty-nine physicians from North America and Europe with expertise relevant to meningiomas were invited to participate. RESULTS: Thirty-four physicians (58%) completed the survey. The reported number of CAYA cancer survivors that physicians are willing to screen to detect one meningioma varied widely from 0 to 750 (median 50). Physicians expressed concerns regarding harms from MRI screening, including risks of unnecessary interventions (n = 25, 73%) and overdiagnosis (n = 19, 56%). Growth pattern (n = 33, 97%), location (n = 31, 91%) and size (n = 29, 85%) were endorsed as the most important factors influencing the decision to treat asymptomatic meningiomas. A challenging location (n = 14, 52%), indolent tumor growth pattern (n = 13, 48%), and absence of symptoms (n = 12, 44%) were endorsed as the main reasons to monitor without intervention. CONCLUSIONS: There is international variation in opinions and clinical practice regarding screening for subsequent asymptomatic meningiomas among at risk CAYA cancer survivors. Decision-making regarding interventions of asymptomatic meningiomas are largely driven by clinical characteristics. These valuable insights into current clinical practice will inform surveillance guidelines for CAYA cancer survivors.
引用
- Verbruggen LC, Hudson MM, Bowers DC, et al. Variations in screening and management practices for subsequent asymptomatic meningiomas in childhood, adolescent and young adult cancer survivors. J Neurooncol. 2020. PMID: 32088813. doi:10.1007/s11060-020-03436-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。